Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults ADDING MULTIMEDIA | BioSpace
TEVA PHARMACEUTICALS POLSKA – Page 2 – Pharmacyapozona
Earnings Preview: What To Expect From Teva Pharmaceutical On Monday
Teva Reports Second Quarter 2022 Financial Results
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook | Business Wire
Drugmaker Teva fueled opioid addiction in New York, jury finds | Reuters
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva Pharmaceuticals on LinkedIn: #top10 #teva #tevapharm #consumerhealthcare #otc